Cargando…
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Generative artificial intelligence offers a fresh view on molecular design. We present the first‐time prospective application of a deep learning model for designing new druglike compounds with desired activities. For this purpose, we trained a recurrent neural network to capture the constitution of...
Autores principales: | Merk, Daniel, Friedrich, Lukas, Grisoni, Francesca, Schneider, Gisbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838524/ https://www.ncbi.nlm.nih.gov/pubmed/29319225 http://dx.doi.org/10.1002/minf.201700153 |
Ejemplares similares
-
Combining generative artificial intelligence and on-chip synthesis for de novo drug design
por: Grisoni, Francesca, et al.
Publicado: (2021) -
Beam Search for Automated Design and Scoring of Novel ROR Ligands with Machine Intelligence
por: Moret, Michael, et al.
Publicado: (2021) -
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design
por: Moret, Michael, et al.
Publicado: (2023) -
Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
por: Merk, Daniel, et al.
Publicado: (2018) -
Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
por: Merk, Daniel, et al.
Publicado: (2018)